Metropolis Healthcare Share Price

NSE: METROPOLIS

₹ 575.00

+₹7.55 (1.33%)

Last updated 24 Jul, 2026, 15:29 IST

Metropolis Healthcare Share Price Today

As of 26 Jul 2026, Metropolis Healthcare share price is ₹575.00. The stock opened at ₹569.90, compared to its previous close of ₹567.45. During today's trading session, Metropolis Healthcare share price moved in the range of ₹565.85 to ₹575.00, with an average price of ₹570.42 for the day. Looking at its last 52-week, the stock has touched a low of ₹412.25 and a high of ₹600.00. On the performance front, Metropolis Healthcare share price has increased by 25.79% over the last six months and is up 12.14% on a year-on-year basis.

₹565.85

1.33% up today

₹575.00

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 22.04% QoQ

Latest Earning

Net Profit TrendUp by 21.07% QoQ

Latest Earning

Revenue TrendUp by 4.32% QoQ

Stock Performance

OutperformingBeat Nifty by 4.14 % in last 1 month

Shareholding Pattern

DIIDII decreased stake by 2.50%

Shareholding Pattern

FIIFII increased stake by 5.76%

Metropolis Healthcare Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹5,79,287+₹79,287 (+15.86%)

3 Year

₹8,31,511+₹3,31,511 (+66.30%)

5 Year

₹4,00,907-₹99,093 (-19.82%)

₹456.20₹684.30

Circuit Low

Circuit High

₹412.25₹600.00

52-Week Low

52-Week High

Circuit

₹456.20

₹684.30

52-week

₹412.25

₹600.00

Mkt Cap Cr

11,841.80

P/E

61.95

P/B

7.83

ROE

12.56%

D/E

0.13

ROCE

16.25%

Div. Yield

0.88%

EPS(TTM)

7.62

Turnover

0.85

EV/EBITDA

28.59

Net Margin

0.00%

Op. Margin

0.00%

ROA

8.94%

Quick Ratio

0.00

Curr. Ratio

1.72

Mkt Cap Cr

11,841.80

P/E

61.95

P/B

7.83

ROE

12.56%

D/E

0.13

ROCE

16.25%

Div. Yield

0.88%

EPS(TTM)

7.62

Turnover

0.85

EV/EBITDA

28.59

Net Margin

0.00%

Op. Margin

0.00%

ROA

8.94%

Quick Ratio

0.00

Curr. Ratio

1.72

Based on fundamentals, this stock's

Performance

Excellent

Metropolis Healt outperforming all market indices

Valuation

Fairly Valued

Metropolis Healt appears to be fairly valued compared to its peers

Earnings

Excellent

Metropolis Healt revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Apollo Hospitals	1,26,592.00	63.21	13.36	20.48%	0.32	17.27%	692.92	0.23%	0.70	103.81
Max Healthcare	1,05,256.00	64.89	8.71	14.33%	0.08	13.72%	10.47	0.21%	0.28	7.37
Fortis Healthcare	71,354.90	57.58	6.06	11.31%	0.22	13.36%	6.50	0.13%	0.16	3.05
Aster DM Healthcare	68,339.10	160.00	14.92	8.48%	0.31	10.10%	53.53	0.23%	0.46	5.20
Narayana Hrudayalaya	40,098.70	49.75	8.84	17.76%	0.75	11.42%	12.63	0.28%	0.85	24.77
Global Health	36,846.20	66.49	9.30	14.05%	0.06	15.26%	149.24	0.04%	0.77	18.46
KRISHNA INST OF MED SCI L	33,485.00	138.41	8.94	10.74%	0.63	7.99%	93.54	0.00%	0.46	6.52
Dr. Lal Path Labs	29,448.90	53.90	11.74	20.13%	0.08	25.56%	147.52	1.17%	0.87	30.45
Poly Medicure	16,891.60	52.67	5.44	10.37%	0.08	12.71%	301.18	0.21%	0.53	33.15
Syngene International	16,413.20	49.65	3.25	7.78%	0.05	9.52%	3.34	0.32%	0.67	7.58

Metropolis Healthcare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹1,331.20	₹1,207.71	₹1,148.21	₹1,228.34
Other Income	₹15.11	₹9.12	₹15.22	₹17.62
Total Revenue	₹1,346.32	₹1,216.83	₹1,163.43	₹1,245.96
Total Expenses	₹1,155.46	₹1,042.14	₹975.93	₹968.51
Profit Before Tax	₹190.85	₹174.69	₹187.50	₹293.35
Tax	₹45.34	₹46.23	₹44.11	₹78.67
Profit After Tax	₹145.51	₹128.46	₹143.39	₹214.69
EPS - Basic	₹28.29	₹24.95	₹27.91	₹41.87
EPS - Diluted	₹28.15	₹24.87	₹27.81	₹41.66

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹190.85	₹174.69	₹187.50	₹293.35
Income before WC changes	₹322.43	₹296.00	₹291.56	₹352.18
Change in Assets	-₹16.20	-₹8.02	₹19.44	-₹11.23
Change in Liabilities	₹0.49	₹13.47	-₹12.33	-₹5.16
Change in WC	-₹15.71	₹5.45	₹7.11	-₹16.40
Cash flow from Operations	₹262.75	₹264.07	₹247.09	₹253.27
Cash flow from Investing	-₹201.06	-₹89.41	₹46.79	-₹737.57
Cash flow from Financing	-₹86.63	-₹181.20	-₹292.33	₹162.52
Total Cash Flow	-₹24.94	-₹6.54	₹1.56	-₹321.78
Cash (Start of the year)	₹62.62	₹68.83	₹65.98	₹386.59
Cash (End of the year)	₹39.48	₹62.62	₹68.83	₹65.98

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1,521.24	₹1,239.23	₹1,198.87	₹1,137.17
Current Assets	₹345.94	₹315.83	₹302.73	₹393.12
Total Assets	₹1,867.18	₹1,555.06	₹1,501.61	₹1,530.29
Current Liabilities	₹294.33	₹245.87	₹264.97	₹301.55
Net Current Asset	₹51.61	₹69.96	₹37.76	₹91.57
Non-Current Liabilities	₹238.20	₹209.91	₹245.93	₹340.58
Equity Capital	₹1,334.64	₹1,099.27	₹990.71	₹888.17
Total Equity & Liabilities	₹1,867.18	₹1,555.06	₹1,501.61	₹1,530.29

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹1,216.54	₹1,103.43	₹1,066.04	₹1,157.01
Other Income	₹17.05	₹12.00	₹21.28	₹16.15
Total Revenue	₹1,233.59	₹1,115.42	₹1,087.32	₹1,173.16
Total Expenses	₹1,071.57	₹958.01	₹908.38	₹917.51
Profit Before Tax	₹162.02	₹157.41	₹178.95	₹271.55
Tax	₹37.23	₹41.52	₹40.00	₹72.01
Profit After Tax	₹124.80	₹115.89	₹138.95	₹199.53
EPS - Basic	₹24.35	₹22.63	₹27.14	₹39.00
EPS - Diluted	₹24.24	₹22.55	₹27.05	₹38.81

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹162.02	₹157.41	₹178.95	₹271.55
Income before WC changes	₹288.40	₹273.92	₹275.06	₹325.88
Change in Assets	₹11.89	₹8.25	₹21.82	-₹3.27
Change in Liabilities	₹8.51	₹14.09	-₹15.12	-₹2.40
Change in WC	₹20.39	₹22.34	₹6.70	-₹5.67
Cash flow from Operations	₹275.01	₹269.01	₹237.74	₹244.04
Cash flow from Investing	-₹196.09	-₹81.00	₹46.72	-₹738.21
Cash flow from Financing	-₹84.50	-₹183.00	-₹287.87	₹171.97
Total Cash Flow	-₹5.58	₹5.01	-₹3.40	-₹322.20
Cash (Start of the year)	₹28.59	₹24.09	₹27.49	₹347.68
Cash (End of the year)	₹22.68	₹28.59	₹24.09	₹27.49

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1,428.78	₹1,200.26	₹1,168.86	₹1,105.36
Current Assets	₹256.12	₹272.44	₹265.44	₹353.18
Total Assets	₹1,684.90	₹1,472.70	₹1,434.29	₹1,458.54
Current Liabilities	₹245.08	₹234.37	₹253.27	₹286.92
Net Current Asset	₹11.04	₹38.07	₹12.17	₹66.26
Non-Current Liabilities	₹195.38	₹207.14	₹245.01	₹332.42
Equity Capital	₹1,244.45	₹1,031.19	₹936.02	₹839.21
Total Equity & Liabilities	₹1,684.90	₹1,472.70	₹1,434.29	₹1,458.54

* All values are in INR Crore

Qty

Bid

Ask

Qty

Bid Total: 0

Ask Total: 0

Buy orders: 0%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bullish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

55.46

Neutral

ATR (14)

18.91

Neutral

STOCH(9,6)

66.59

Neutral

STOCH RSI (14)

53.87

Neutral

ADX(9)

14.3

Bullish

UO(9)

47.6

Neutral

ROC(12)

3.8

Bullish

WillR(14)

-33.41

Neutral

Period

Simple value

Exponential vaue

570.07

568.51

10D

566.97

566.28

20D

559.63

560.57

50D

544.37

543.08

100D

506.95

522.76

About Metropolis Healthcare

ISIN

INE112L01020

Sector Market Cap

₹ 11,841.8 Cr

Engaged in diagnostic services, Metropolis Healthcare Limited offers a range of clinical laboratory tests and profiles used for early detection, confirmation and monitoring of disease. It also offers analytical and support services to clinical research organisations for their clinical research projects. The company’s services include pathology testing services, corporate wellness, clinical research services and labs in hospitals. Metropolis Healthcare owns diagnostic centres in the Middle East, South Asia and Africa along with its network in India spread across more than 220 cities.

Metropolis has invested in a variety of specialised tests and several advanced tests and technologies introduced in the global market. The company has nearly 2800 specialised tests.

Business operations

Metropolis Healthcare was started in 1980 as a single diagnostic laboratory in Mumbai by Dr Sushil Kanubhai Shah. The company became a public entity in 2006 and was renamed Metropolis Health Services (India) Limited. The company established its first referral laboratory in 1981. Metropolis started clinical research services in 1992. Ameera Sushil Shah joined the team of Metropolis as one of the partners in the company in 1998. She played a major role in the company's growth strategy and was key to its expansion. In 2001, the company completed its first major acquisition and took over the business of Sudharma, Kerala, in 2001. The same year the company introduced its home service vertical.

In 2006, Metropolis received capital funding from ICICI Ventures. The company executed a secondary transaction by Foxcreek Investment Limited, an affiliate company of Warburg Pincus. The company sets its foot outside the Indian market, taking its services to developing African countries. In 2015, Warburg Pincus exited the company, giving the promoters management control of the firm.

The company inducted a new professional team and rolled out the Metropolis retail strategy in 2016.

In 2019-20, was a year of growth for the company as it pushed for retail expansion. Metropolis also initiated its first public-private partnership (PPP). The company launched its initial public offering (IPO) and was listed on the Indian stock markets.

In 2021-22, the company acquired Hitech Diagnostics Centre to boost its presence in the South Indian markets. It also initiated a network expansion project (90:30) with 90 labs and 1,800 service collection centres in tier 2 and tier 3 cities across India. Metropolis absorbed 8 wholly-owned subsidiaries into the company.

It also became the industry’s first firm to introduce an Employee Value Proposition (EVO). The company rolled out the Metropolis 3.0 strategy to expand its consumer reach via a direct-to-consumer model.

As of January 10, 2024, the company’s market capitalisation is valued at over ₹ 8,200 crores. Metropolis Healthcare’s share price has slipped by over 23% in the last three years.

Metropolis Healthcare Financial Highlights

Revenue: Metropolis Healthcare reported revenue of ₹1,671.43 crore in FY26 vs ₹1,346.31 crore in FY25. It showed an increase of 24.15% on a yearly basis.
Operating Profit: Metropolis Healthcare reported an operating profit of ₹259.18 crore in FY26 vs ₹190.85 crore in FY25. It showed an increase of 35.80% on a year-on-year basis.
Net Profit: Metropolis Healthcare reported a net profit of ₹191.18 crore in FY26 vs ₹145.51 crore in FY25. It showed an increase of 31.39% on a yearly basis.

Metropolis Healthcare Quarterly Result Highlights

Metropolis Healthcare reported revenue of ₹432.84 crore in Mar 2026, compared with ₹414.93 crore in Dec 2025, representing an increase of 4.32% on a quarter-on-quarter (QoQ) basis.
Metropolis Healthcare reported an operating profit of ₹69.76 crore in Mar 2026, compared with ₹57.16 crore in Dec 2025, representing an increase of 22.04% on a quarter-on-quarter (QoQ) basis.
Metropolis Healthcare reported a profit of ₹50.96 crore in Mar 2026, compared with ₹42.09 crore in Dec 2025, reflecting an increase of 21.07% on a QoQ basis.
The earnings per share (EPS) of Metropolis Healthcare stood at ₹28.29 during Mar 2026.